Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Increasing evidence showed that long non-coding RNAs (lncRNAs) play critical roles in tumor progression.
FEZF1
-AS1 is a
cancer-associated
lncRNA which upregulated and associated with poor prognosis in patients with cancer. However, the roles of
FEZF1
-AS1 in multiple myeloma (MM) remains unclear. In the present study, our data revealed that
FEZF1
-AS1 expression was increased both in MM samples and cell lines. Loss of functional assays indicated that
FEZF1
-AS1 suppression inhibited MM cells proliferation, arrested cell cycle in G0/G1 phase and induced cell apoptosis in vitro. Furthermore, our data indicated that
FEZF1
-AS1 functioned as a competing endogenous RNA in MM cells that regulated miR-610 expression, which suppressed Akt3. Those data showed that
FEZF1
-AS1 promoted MM cells proliferation through regulating miR-610/Akt3 axis, suggesting
FEZF1
-AS1 could be served as a potential target for cancer therapeutics in MM.
...
PMID:Long non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma via miR-610/Akt3 axis. 2986 63